Expertise in
1
conditions

Kefeng Q. Ding

No. 88 Jiefang Road, 31009, 
Hangzhou, CN 
Expertise in
1
conditions
No. 88 Jiefang Road, 31009, 
Hangzhou, CN 
OverviewLocationsClinical Research

Overview

Kefeng Ding practices in Hangzhou, China. Ding is highly rated in 1 condition, according to our data. Their top areas of expertise are Colorectal Cancer, Fecal Impaction, Liver Cancer, Colonoscopy, and Endoscopy.

Their clinical research consists of co-authoring 139 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

No. 88 Jiefang Road, 31009, Hangzhou, China
Other Locations
No. 88, Jiefang Road, Hangzhou, China
Jiefang Road 88, Hangzhou, 310009, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2024
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Randomized, Open-label, Parallel Controlled, Multi-center Phase III Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
A Randomized, Open-label, Parallel Controlled, Multi-center Phase III Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

139 Total Publications

An Activated Gasdermin Mimicking Polymer for Antitumor Immunity.
An Activated Gasdermin Mimicking Polymer for Antitumor Immunity.
Journal: ACS nano
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ding's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile